News | June 18, 2014

Leading Cardiac Surgeons Share Their Experiences With New Blood Removal Technology

ClearFlow PleuraFlow Active Clearance Technology

June 18, 2014 — Distinguished physicians from leading cardiac surgery centers gathered at an educational symposium to share their experiences with a new-generation blood evacuation system for use following cardiothoracic surgical procedures. ClearFlow Inc. hosted the symposium at the recent American Association of Thoracic Surgeon’s meeting in Toronto, Canada, where its award-winning technology was on exhibit for more than 2,400 cardiac surgeons and healthcare professionals.

Marc Gillinov, M.D., a surgeon from the Cleveland Clinic, discussed the incidence and consequences of the complications that can result from the incomplete evacuation of blood from a patient’s chest after cardiac surgery. Louis Perrault, M.D., from Montreal Heart Institute described the lack of best practices regarding the maintenance of chest tube patency after surgery, and discussed the opportunity for implementing new protocols to enhance patient care in this area. Brian Bruckner, M.D., shared the unique needs of ventricular assist device (VAD) patients with respect to managing their post-operative bleeding. “It was exciting to hear these esteemed physicians share their positive experiences with the PleuraFlow Active Clearance Technology,” stated the panel moderator and company founder and chairman, Edward Boyle, M.D.

“At the heart of our mission is a goal to dramatically reduce the common occurrence of chest tube occlusion that leads to death and injury in this patient population,” said ClearFlow president & CEO, Paul Molloy. “Patients are experiencing unnecessary pain and additional procedures and most hospitals are shouldering the burden of extensive cost increases due to lack of consistent protocols and unacceptable failure with current products used for wound drainage post-cardiac surgery.”

For more information: www.clearflow.com

Related Content

Open Heart Surgery Outperforms Stents in Patients With Multivessel Disease
News | Cardiovascular Surgery | May 03, 2019
Coronary artery bypass grafting (CABG) surgery may be the best treatment option for most patients with more than one...
SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Overlay Init